(19)
(11) EP 2 425 800 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
28.01.2015 Bulletin 2015/05

(45) Mention of the grant of the patent:
17.12.2014 Bulletin 2014/51

(21) Application number: 11185045.9

(22) Date of filing: 06.11.2002
(51) International Patent Classification (IPC): 
A61F 2/07(2013.01)
A61F 2/90(2013.01)
 A61F 2/82(2013.01)

(54)

Implantable intraluminal device and method of using same in treating aneurysms

Implantierbare intraluminale Vorrichtung und Verfahren zu ihrer Verwendung bei der Behandlung von Aneurysmen

Dispositif intraluminal implantable et méthode d'utilisation associée dans le traitement d'anévrysmes

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

(30) Priority: 23.11.2001 US 332013 P
12.08.2002 US 216356

(43) Date of publication of application:
07.03.2012 Bulletin 2012/10

(62) Application number of the earlier application in accordance with Art. 76 EPC:
02785876.0 / 1455679

(73) Proprietors:
  • Stryker Corporation
    Kalamazoo, MI 49002 (US)
  • Stryker European Holdings I, LLC
    Kalamazoo MI 49002 (US)

(72) Inventors:
  • Yodfat, Ofer
    71 700 Modi'in (IL)
  • Lieber, Baruch
    Aventura, FL Florida 33180 (US)
  • Grad, Ygael
    69 512 Tel Aviv (IL)
  • Nishri, Boaz
    37 805 Maagan (IL)

(74) Representative: Röthinger, Rainer 
Wuesthoff & Wuesthoff Patent- und Rechtsanwälte Schweigerstrasse 2
81541 München
81541 München (DE)


(56) References cited: : 
WO-A-99/02092
US-A- 4 655 771
 WO-A-03/006097
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).